OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
December 09, 2020
Cytiva is adding process development, media and assay development, and contract development services at its facilities in Korea, Japan, Sweden, and the UK.
December 03, 2020
Set to be operational by the first quarter of 2022, the 140,000-ft2 facility will feature up to six 2000-L, single-use bioreactor systems along with additional harvest and purification equipment to produce up to 100 commercial batches annually.
November 04, 2020
Biopharma can apply new manufacturing practices adopted during the COVID-19 pandemic to enhance bioprocessing.
November 02, 2020
The latest advances in downstream technologies include sterile disconnects for single-use manufacturing systems, ligand technologies for purifying RNA and for COVID-19 vaccines, and an automated perfusion system.
October 16, 2020
The new facility at the company’s San Diego, CA, site will be for late phase and commercial CGMP manufacturing.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
September 02, 2020
The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
September 01, 2020
Facility and equipment design are important, but the team and its experience matter most.
August 02, 2020
New therapeutics modalities and the need for greater process efficiency are driving technology development.
July 02, 2020
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.